These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37057368)
1. The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments. Salehi Omran H; Naghashzadeh F; Irilouzadian R; Dolatshahi S; Hedayati Goudarzi MT; Salehi Omran MT Clin Cardiol; 2023 Jun; 46(6):674-679. PubMed ID: 37057368 [TBL] [Abstract][Full Text] [Related]
2. Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy. Salehi Omran H; Irilouzadian R; Hedayati Goudarzi MT; Salehi Omran MT Clin Cardiol; 2023 Oct; 46(10):1297-1298. PubMed ID: 37605641 [TBL] [Abstract][Full Text] [Related]
3. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation. Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. Kadish A; Dyer A; Daubert JP; Quigg R; Estes NA; Anderson KP; Calkins H; Hoch D; Goldberger J; Shalaby A; Sanders WE; Schaechter A; Levine JH; N Engl J Med; 2004 May; 350(21):2151-8. PubMed ID: 15152060 [TBL] [Abstract][Full Text] [Related]
5. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy. De Angelis G; Merlo M; Barbati G; Bertolo S; De Luca A; Ramani F; Adamo L; Sinagra G J Am Soc Echocardiogr; 2022 Aug; 35(8):801-809.e3. PubMed ID: 35367610 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy. Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359 [TBL] [Abstract][Full Text] [Related]
8. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls. Pezawas T; Diedrich A; Winker R; Robertson D; Richter B; Wang L; Byrne DW; Schmidinger H Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1101-8. PubMed ID: 25262115 [TBL] [Abstract][Full Text] [Related]
9. Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis. Stolfo D; Albani S; Savarese G; Barbati G; Ramani F; Gigli M; Biondi F; Dal Ferro M; Zecchin M; Merlo M; Sinagra G Int J Cardiol; 2020 May; 307():75-81. PubMed ID: 32067834 [TBL] [Abstract][Full Text] [Related]
10. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. Gulati A; Jabbour A; Ismail TF; Guha K; Khwaja J; Raza S; Morarji K; Brown TD; Ismail NA; Dweck MR; Di Pietro E; Roughton M; Wage R; Daryani Y; O'Hanlon R; Sheppard MN; Alpendurada F; Lyon AR; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK JAMA; 2013 Mar; 309(9):896-908. PubMed ID: 23462786 [TBL] [Abstract][Full Text] [Related]
11. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction. Muhammed A; Abdelazeem M; Elewa MG; Sharief M; Ammar A Heart Fail Rev; 2023 Jan; 28(1):229-240. PubMed ID: 35587303 [TBL] [Abstract][Full Text] [Related]
12. Survival, ventricular arrhythmia, and implantable cardioverter-defibrillator usefulness in toxic cardiomyopathy due to substance abuse. Dognin N; Rimac G; Domain G; Cinq-Mars A; Massot M; Turgeon PY; Dubois-Sénéchal SM; Bourgault C; Morin J; Bernier M; Beaudoin J; Laflamme M; Charbonneau E; Strubé C; Voisine P; Philippon F; Belzile D; Sénéchal M Pacing Clin Electrophysiol; 2023 Jul; 46(7):645-656. PubMed ID: 37247219 [TBL] [Abstract][Full Text] [Related]
13. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior]. Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803 [TBL] [Abstract][Full Text] [Related]
14. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517 [TBL] [Abstract][Full Text] [Related]
15. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy. Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132 [TBL] [Abstract][Full Text] [Related]
16. Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more. Makati KJ; Fish AE; England HH; Tighiouart H; Estes NA; Link MS Heart Rhythm; 2006 Apr; 3(4):397-403. PubMed ID: 16567284 [TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials. Wolff G; Lin Y; Karathanos A; Brockmeyer M; Wolters S; Nowak B; Fürnkranz A; Makimoto H; Kelm M; Schulze V Clin Res Cardiol; 2017 Jul; 106(7):501-513. PubMed ID: 28213711 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function. Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695 [TBL] [Abstract][Full Text] [Related]
19. Non-invasive markers for sudden cardiac death risk stratification in dilated cardiomyopathy. Pooranachandran V; Nicolson W; Vali Z; Li X; Ng GA Heart; 2022 Jun; 108(13):998-1004. PubMed ID: 34670824 [TBL] [Abstract][Full Text] [Related]
20. Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy. Di Marco A; Brown PF; Bradley J; Nucifora G; Claver E; de Frutos F; Dallaglio PD; Comin-Colet J; Anguera I; Miller CA; Schmitt M J Am Coll Cardiol; 2021 Jun; 77(23):2890-2905. PubMed ID: 34112317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]